Background and Purpose-Stroke is the second leading cause of hospital admission among older adults in the United
T
here are an estimated 795 000 stroke cases and 133 000 stroke deaths annually in the United States. 1 Stroke is the third leading cause of death and a leading cause of disability in the United States. Ischemic stroke disproportionately affects older patients who have a greater incidence and prevalence of ischemic stroke than younger individuals. [1] [2] [3] Population-based studies indicated that 65% of all strokes occur at age Ն65 years. 3, 4 Older patients with ischemic stroke also have worse functional outcomes than younger patients. 3 Stroke, as the second leading cause of hospital admission among the elderly, places a significant economic burden (estimated at $20.2 billion in direct hospital costs) on the American healthcare system. 1 National quality profiling efforts have recently begun to report hospital-level performance across the country for common medical conditions. 5 Risk-standardized mortality rates within 30 days of admission for heart failure and acute myocardial infarction and risk-standardized rehospitalization rates within 30 days of discharge for Medicare beneficiaries are now publicly reported for US hospitals. [5] [6] [7] To date, there are only a limited number of contemporary studies examining the full burden of hospital readmission and mortality after ischemic stroke at the patient level, 8, 9 and data examining the variation in outcomes between hospitals are extremely limited. Whether hospital-level outcomes vary when considering important patient characteristics has also not been well studied, and there is little understanding of the hospital characteristics associated with postdischarge outcomes for patients with ischemic stroke, especially among Medicare beneficiaries, which serve as the primary population for public reporting. Using data from ischemic stroke admissions in the Get With The Guidelines-Stroke (GWTG-Stroke) Program linked to Medicare data, the objectives of this study were to: (1) quantify the rates of hospital readmission and mortality 30 days and 1 year after ischemic stroke for Medicare beneficiaries; (2) identify the extent to which these outcomes vary by hospitals and which hospital characteristics are associated with outcomes after adjusting for differences in patient characteristics; and (3) determine if there have been improvements in mortality and readmission from 2003 to 2006.
Methods

Data Sources
Data from the GWTG-Stroke registry was linked with enrollment files and inpatient claims from the Centers for Medicare & Medicaid Services for the period April 1, 2003, through December 31, 2006. Follow-up continued through the end of 2007. The design, inclusion criteria, and data collection methods for GWTG-Stroke have been previously published. 3, 10, 11 Briefly, patients were eligible for inclusion in the GWTG-Stroke registry if they were admitted for acute stroke. Trained hospital personnel ascertained acute stroke admissions by prospective clinical identification, retrospective identification using International Classification of Diseases, 9th Revision discharge codes, or a combination. Patient data abstracted by trained hospital personnel included demographics, medical history, brain imaging, in-hospital treatment and events, discharge treatment and counseling, mortality, and discharge destination. All patient data were deidentified before submission. All states and regions of the United States were represented and a variety of centers participated, from community hospitals to large tertiary centers. Data on hospitallevel characteristics (ie, bed size, academic or nonacademic status, annual volume of stroke discharges, and geographical region) were obtained from the American Hospital Association. 12 Geographic region was defined by US Census Bureau designations. Hospitals were also classified as to whether they were certified as a primary stroke center by The Joint Commission.
All participating institutions were required to comply with local regulatory and privacy guidelines and, if applicable, to obtain Institutional Review Board approval. Outcome Sciences, Inc (Cambridge, Mass) served as the registry coordinating center. The Duke Clinical Research Institute (Durham, NC) served as the data analysis center.
The Centers for Medicare & Medicaid Services files (100% Medicare research identifiable files) included data for all fee-forservice Medicare beneficiaries aged Ն65 years who were hospitalized with a diagnosis of acute stroke (International Classification of Diseases, 9th Revision 430.x, 431.x, 433.x, 434.x, and 436.x). We merged patient data in the GWTG registry with Medicare Part A inpatient claims, matching by admission and discharge dates, hospital, date of birth, and sex using methods previously described. 13, 14 Of 222 278 hospitalizations of patients aged Ն65 years in GWTGStroke, we matched 157 039 patients (69%) to fee-for-service Medicare claims from 850 hospitals. Patients in Medicare managed care plans (15% to 25% of the population depending on the region of the country) or other types of insurance are not included in fee-for-service Medicare claims files and therefore cannot be matched. 13, 14 The study population then was confined to patients with acute ischemic stroke (nϭ101 801), first index stroke admission April 2003 or later, and further confined to the first index admission (nϭ94 421). Hospitals and patients from centers with Ͻ25 patients with ischemic stroke were excluded to minimize the likelihood of sampling errors. This resulted in a final study population of 91 134 patients with acute ischemic stroke from 625 GWTG-Stroke hospitals. The demographics, clinical characteristics, and geographic distribution of matched and unmatched acute ischemic stroke cases were similar, except fewer patients were enrolled in GWTG-Stroke from the Midwest compared with unmatched ischemic stroke cases. GWTG-Stroke participation rates by geographic region are shown in the Supplemental Appendix (available at http://stroke.ahajournals.org).
Outcomes
The primary outcomes of interest were all-cause mortality within 30 days from time of admission, all-cause mortality or rehospitalization within 30 days from time of hospital discharge, all-cause mortality within 1 year from time of hospital discharge, and all-cause mortality or rehospitalization within 1 year from time of hospital discharge. Rehospitalization was defined as an admission to an acute care hospital for any reason within the specified timeframe from discharge after an index hospitalization. Like with other studies of Medicare beneficiaries, we obtained, with complete ascertainment, deaths and dates of death from the Centers for Medicare & Medicaid Services vital status files. Readmissions and readmission dates were obtained from Part A inpatient claims. 13 Transfer out to or subsequent admission into inpatient stroke rehabilitation was not considered as hospital readmission. The Centers for Medicare & Medicaid Services uses the convention of reporting hospital mortality rates from the time of admission, whereas it reports readmission rates among survivors from the time of hospital discharge. Accordingly, in this study, hospital deaths were included in the reported rates for 30-day, 90-day, and 1-year mortality rates from time of admission but were not included in the reported rates of 30-day, 90-day, and 1-year mortality from time of discharge and 30-day, 90-day, and 1-year mortality or rehospitalization from time of discharge. Readmissions within 30 days of discharge and 1 year of discharge were also categorized by underlying cause using the associated Diagnostic-Related Group primary discharge diagnosis grouped as previously described (Supplemental Appendix). 8 
Statistical Analysis
We summarized baseline characteristics by treatment group using percentages for categorical variables and means and SDs for continuous variables. For comparisons by group, we used 2 tests for categorical variables and Kruskal-Wallis tests for continuous variables. Multivariable logistic models were developed with hospital effect fitted as a random intercept (through PROC GLIMMIX using SAS) to account for interhospital heterogeneity. The candidate variables for risk models included those previously identified in GWTG-Stroke: age, sex, race, on-hour arrival time to hospital (Monday through Friday 7 AM to 5 PM, yes/no), emergency medical service transport (yes/no), medical history and risk factors (including atrial fibrillation, previous stroke/transient ischemic attack, coronary heart disease or prior myocardial infarction, carotid stenosis, diabetes, peripheral vascular disease, hypertension, dyslipidemia, and current smoking). 3, 11 Of all the key model covariates, only 1908 (2.1%) records had Ն1 missing observations. In the regression models, missing race is imputed as white and missing medical history is imputed as no medical history. Risk-adjusted rates were calculated using observed to expected ratio. That is, risk adjusted rateϭobserved/expected*national overall rate. These results were then used to assess the variability in risk-adjusted outcomes, rank hospitals into percentiles of performance by outcome, and compare risk-adjusted outcomes between different types of hospitals. Model discrimination was assessed by determining the c statistic for each model. Sensitivity analyses were performed assessing hospital variation after also adjusting for National Institutes of Health Stroke Scale (NIHSS) in the subgroup of patients with NIHSS recorded (after excluding hospitals with Ͻ10 patients with ischemic stroke with NIHSS recorded). We also examined differences in riskadjusted mortality and readmission rates by specific hospital characteristics, including stroke volume, teaching status, primary stroke center, and geographical region, by fitting multivariable regression models with generalized estimating equation and Sandwich variance estimation method to address the within-site correlation. Time trends for each clinical outcome were compared by Cochran-MantelHaenszel tests. SAS software version 9.2 (SAS Institute Inc, Cary, NC) was used for all analyses.
Results
There were 91 134 patients with ischemic stroke in the study cohort. There was a median 102 patients with ischemic stroke per hospital (25th to 75th percentile 54 to 199). The patient characteristics are shown in Table 1 . The mean age was 79.3Ϯ7.9 years, 57.9% were women, and 82.4% were white. (Table 1) . There were 5662 (6.1%) patients who died during the index ischemic stroke hospitalization (Supplemental Table I ). The mean hospital rate for death within the first 30 days from time of admission to the hospital was 14.1%. After excluding inpatient deaths and with follow-up beginning from the time of hospital discharge, the mean rate of death within 30 days from the time of hospital discharge was 10.0%. The hospital mean rate for death or rehospitalization within 30 days of hospital discharge was 21.5%. Within the first year after hospital discharge, the hospital-level death rate was 26.7%, readmission rate 56.2%, and death or readmission rate was 61.9%. The event rates after risk adjustment are shown in Table 2 and also show rehospitalizations and death are frequent after ischemic stroke. Patients who were readmitted within 30 days of discharge were more likely to die within 30 days of discharge compared with patients who were not readmitted (12.9% versus 9.6%, PϽ0.0001). Patients who were readmitted within 30 days of discharge were also more likely to die within the first year of discharge compared with patients who were not readmitted (42.6% versus 24.2%, PϽ0.0001).
The variation across hospitals for unadjusted 30-day mortality after admission and 1-year mortality after hospital discharge and 30-day mortality or readmission after discharge, respectively, are shown in Supplemental Table I , whereas risk-adjusted rates are shown in Table 2 . There is an approximately 2-fold difference in unadjusted outcomes between the 10th and 90th percentile hospitals at 30 days, 90 days, and 1 year after discharge. After risk adjustment, there was still substantial variation in 30-day, 90-day, and 1-year clinical outcomes at the hospital level ( Table 2) . The hospitallevel 30-day risk-adjusted death after admission for hospitals at the 10th percentile was 9.8% compared with 17.8% at the 90th percentile. The 30-day death or readmission rate after discharge was 15.8% for hospitals at the 10th percentile and 26.3%, for patients at the 90th percentile. There was also substantial variation in 1-year risk-adjusted clinical outcomes at the hospital level ( Table 2 ). The c statistics for the mortality models were 0.70 to 0.71 indicating good discrimination. For the rehospitalization models, the c statistics were 0.59 to 0.62, indicating modest discrimination. The interhospital variances in the clinical outcome rates were reduced by approximately one third to two thirds after adjusting for patient characteristics, yet substantial hospital-level variation in death and rehospitalization persist ( Table 2 ). In sensitivity analyses confined to the subgroup of patients with NIHSS recorded and after adjusting for stroke severity, substantial variation in 30-day, 90-day, and 1-year clinical outcomes at the hospital level were still observed (Supplemental Tables II and III) .
Patient and hospital characteristics among hospitals stratified by quartiles of mortality rates in the first 30 days from admission are shown in Table 1 . Patients in hospitals with higher 30-day from admission mortality rates were slightly older, more likely to be white, had a higher frequency of atrial fibrillation, and modestly higher stroke severity. Patients in these hospitals had on average worse in-hospital outcomes with higher in-hospital mortality rates, less patients discharged home, and less patients were able to ambulate without assistance. In risk-adjusted analyses stratified by hospital characteristics, there were no significant or only modest differences in risk-adjusted mortality rates and readmission rates by hospital ischemic stroke volume and primary stroke center status ( Table 3 ). The 30-day readmission rates were comparable across volume of patients with stroke, teaching status, and whether the hospital was designated as a primary stroke center. Geographic region was associated with slight differences in 30-day rehospitalization (PϽ0.0001). There were also statistically significant differences in 1-year outcomes (death and death/rehospitalization) by certain hospital characteristics; rates were slightly lower for academic hospitals compared with nonacademic hospitals and slightly lower for hospitals located in the West and Northeast compared with the South or Midwest (PϽ0.0001). Even those hospital characteristics that were significant had only a minor influence on the variation in clinical outcomes adjusted for patient characteristics. Altogether these 4 hospital characteristics accounted for only 2% to 5% of the variation in hospital-level clinical outcomes. There were higher-and lower-performing hospitals among each type of hospital for each of the clinical outcomes. The most frequent principal Diagnostic-Related Groups associated with readmissions within 30 days and 1 year are presented in Supplemental Table IV Adjusted for patient characteristics: age, sex, minority (yes/no); on-hour arrival time (yes/no); emergency medical services transport (yes/no); and medical histories (including atrial fibrillation, previous stroke/transient ischemic attack, coronary artery disease/prior myocardial infarction, carotid stenosis, diabetes mellitus, peripheral vascular disease, hypertension, smoking, and dyslipidemia). Hospital effect is fitted as a random intercept in the generalized mixed effect models. C-statistics for the models are as follows: death rates in 30 days after admission 0.70, death rate in 1 year after discharge 0.71, rehospitalization in 30 days after discharge 0.59, rehospitalization rates in 1 year after discharge 0.62, death or rehospitalization rate in 30 days after discharge 0.70, death or rehospitalization in 1 year after discharge 0.64. Reported risk-adjusted hospital level outcome rates are calculated as observed/expected. *National average rates. †From time of admission to ϫ days after admission. ‡From time of discharge to ϫ days after discharge among those discharged alive. Risk-adjusted outcomes are presents as median (25th, 75th) stratified by hospital characteristics.
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14.4% in 2006. There were likewise no significant differences in 1-year outcomes during the 4-year study period.
Discussion
In this assessment of clinical outcomes after acute ischemic stroke among GWTG-Stroke Medicare beneficiaries in the United States, this study finds that both mortality and rehospitalization were high. Nearly one third of patients with ischemic stroke died within 1 year of admission for ischemic stroke and nearly two thirds died or were rehospitalized within 1 year of hospital discharge. The majority of early and late rehospitalizations were for noncerebrovascular, noncardiovascular reasons. This study also demonstrates that even after risk adjustment, there was significant variation among hospitals for mortality and rehospitalization at 30 days and 1 year. Of the hospital characteristics examined, including region of the country, bed size, academic status, and The Joint Commission primary stroke center designation, only geographical region and academic status were independently associated with risk-adjusted fatal and nonfatal outcomes after ischemic stroke. Even among those hospital characteristics associated with outcomes, these associations accounted for only a very small amount of variation and there were higher-and lower-performing hospitals among each type of hospital for each of the clinical outcomes. The clinical outcomes studied among Medicare beneficiaries after acute ischemic stroke showed no temporal improvements from 2003 to 2006. These findings highlight the importance in understanding the correlates and causes of readmission and death after ischemic stroke and the need to implement strategies and systems to avoid potentially preventable readmissions and death. This study demonstrates that outcomes early after hospitalization for ischemic stroke for Medicare beneficiaries at the hospital level are often poor. The hospital mortality rates for patients with ischemic stroke are nearly 15% within 30 days of admission and the postdischarge mortality or readmission rates for hospitals are Ͼ60% within 1 year after discharge. Only limited data were previously available on the burden of readmissions after stroke. 8, 9, [15] [16] [17] [18] Existing data were often derived from restricted cohorts, typically from a single or small number of institutions, limited geographic area, select clinical trial patient populations, short follow-up, or focused on a limited number of outcomes. 8, 9, [15] [16] [17] [18] In addition, few studies have been performed within the United States. 8 One prior study using administrative claims from a single state showed similarly poor outcomes among Medicare beneficiaries. 8 A Canadian hospital record study reported the 28-day case fatality rate for ischemic stroke was 14.6% and 1-year all-cause readmission rate of 37.9% in 2000 to 2001. 9 The present study builds on these results by presenting more contemporary data from all regions of the country and highlighting important clinical variables that may allow clinicians to target in-care transitions and outpatient follow-up.
This study also analyzed the degree of variation by hospitals after risk adjustment for case mix and clustering of care. This GWTG-Stroke Centers for Medicare & Medicaid Services-linked analysis demonstrates there were substantial differences in the risk of mortality and mortality or readmission among hospitals at the lowest and highest deciles. This difference, which was noted as early as 30 days after discharge, persisted through the first year after discharge. This suggests there may be significant variation in care processes and systems of care in-hospital, during transition of care, and during the postdischarge management. 19 -21 Standardizing evidence-based practices that focus on reducing the risks of preventable deaths or readmissions may be critical. Prior studies have suggested that quality improvement efforts in stroke and other cardiovascular disease states may improve patient outcomes. 20, 22, 23 This analysis also highlights several areas potentially amenable for quality improvement efforts. Many patients with acute ischemic stroke arrived by private transport. This reinforces the need for further patient and public education on the importance of calling for emergency medical services (eg, 911) immediately in response to detection of stroke symptoms. Stroke severity was measured and documented in only 37% of patients, yet it is an important component of basic stroke patient assessment and determination of prognosis. A portion of readmissions is cerebrovascular or cardiovascular and these may be amendable to better secondary prevention efforts. 19, 22 Steps for prevention of noncardiovascular conditions such as pneumonia should also be considered in this population, especially because over half of readmissions are for noncardiovascular causes. 24 Interestingly, some hospital characteristics that were explored in this study such as being a designated primary stroke center and higher stroke patient volume were not significantly associated with better clinical outcome rates or lesser variations in outcomes at the hospital level. It may be that because all hospitals were participating in the GWTG-Stroke performance improvement program that this tended to diminish any potential influence of other hospital characteristics on clinical outcomes. 10 The large variation in event rates by hospital could be due to residual confounding from known and unknown clinical, psychosocial, economic, access to care, or treatment variables. Importantly, stroke severity could not be adjusted for the overall population in the models because the NIHSS or other stroke severity scales are not routinely collected in clinical practice. However, in the subgroup of patients in which NIHSS was collected, there was still substantial hospital-level variation in death and readmission, even after adjusting for NIHSS. Nevertheless, the differences observed in outcomes of hospitals may still be the result of differences in patient case mix as opposed to variation in care and systematic practices. There may be differences between hospitals with higher event rates compared with hospitals with lower event rates for other important variables that were not explored in this study, including differences in the use of evidence-based therapies. As evident by patients' comorbid conditions, ambulatory status, and disposition at discharge, many of these patients may have been quite impaired and a portion of these postdischarge events may not have been preventable, even with improved transitional and outpatient care. The administrative claims data used to discern the primary Diagnostic-Related Group discharge diagnosis for rehospitalization also lack detailed information necessary to draw inferences about whether rehospitalizations were pre-ventable and the underlying causes of differences in readmission rates across hospitals. 8 There have been no improvements observed in risk adjusted 30-day or 1-year outcomes among Medicare beneficiaries hospitalized with acute ischemic stroke and included in this study from 2003 to 2006. These findings help define the frequency, timing, and variation for hospital readmission and should inform clinicians, investigators, and policymakers in identifying opportunities for application of targeted quality improvement and preventive strategies after ischemic stroke. Readmission was chosen in addition to mortality because it is expensive to the healthcare system and may represent a potentially preventable, adverse event for patients. 6 -8 Between of the acute presentation with an ischemic stroke and a readmission to the hospital or postdischarge death, a window of opportunity exists for interventions to reduce the burden of postischemic stroke morbidity and mortality. 25 Early readmissions are likely attributable to the acuity of the presenting ischemic stroke, comorbid conditions as well as the care delivered both during the index hospitalization and the transition period immediately after discharge. 8 The presentation of these hospital-level variations for these ischemic stroke outcomes and the recognition of patterns of performance may lead to efforts to better understand the key determinants of clinical outcomes and identify means to improve ischemic stroke patient outcomes.
Limitations
There are several limitations in this study to consider. This study includes only patients in fee-for-service Medicare and thus does not include patients who were enrolled in managed care, the uninsured, and patients Ͻ65 years of age. Mortality and rehospitalization rates may be lower among patients with ischemic stroke with other types of insurance and there may have been less variation in hospital-level events rates had all patients with stroke been analyzed. The hospitals studied are those participating in GWTG-Stroke and may not be representative of all hospitals caring for patients with acute ischemic stroke. 10 The degrees of variations in clinical outcomes are likely conservative given that hospitals volunteer to participate in this quality improvement registry. The discrimination for the readmission and death/readmission models are lower than the mortality model but are in the range of the models used by Medicare to publicly report hospital 30-day rehospitalization rates for acute myocardial infarction and heart failure. 5, 7 The models used in this study factored in age, race/ethnicity, and multiple comorbidities; however, the variables used in the models are based on patient information at admission rather than at discharge so as to not adjust for hospital events that may be associated with quality of care. The result, however, is that the models do not include all the factors that could improve prediction. It was not possible to account for stroke severity in the overall analysis because the NIHSS is inconsistently documented in clinical practice. We also were not able to adjust for socioeconomic factors, which may have important influence on clinical outcomes. The aims of the models used in this study were to profile hospital quality of care, including what happened during the hospitalization and the period afterward including adherence to follow-up. There are likely other measured or unmeasured confounding variables that, had they been adjusted for, would have altered the findings on hospital variation in outcomes. Despite excluding hospitals with Ͻ25 ischemic stroke admissions, the smaller-volume hospitals included in the study provide less patient data on which to estimate hospital level outcomes. This issue is addressed in part by combining 4 years of ischemic stroke data. We did not assess other important outcomes, including health-related quality of life, disability, patient satisfaction, or other clinical outcomes, that may be of interest.
In summary, nearly two thirds of Medicare beneficiaries discharged from the hospital after ischemic stroke die or are readmitted within 1 year. Hospital-level rates of death or readmission after an acute ischemic stroke hospitalization vary considerably. Although risk-adjusted outcomes did not significantly differ by size or primary stroke center designation, academic hospitals and those in the Northeast and West had slightly more favorable risk-adjusted outcomes. There have been no improvements in death or rehospitalization rates for Medicare beneficiaries with acute stroke from 2003 to 2006. These findings underscore the need for quality improvement interventions and systems of care that will improve early, intermediate, and long-term outcomes of patients with acute ischemic stroke.
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